SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
Samsung, Union Edge Closer to Deal as Strike Threat Looms 
BlackRock-Led GCC Infrastructure Partnership Targets $30 Billion Investment 
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial 
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan 
Alphabet Raises Record $3.6 Billion in Yen Bonds to Support AI Expansion 
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes 
Elliott Targets Bio-Rad as Shares Continue to Struggle 
Nvidia’s China AI Chip Sales Remain Frozen Despite U.S. Approval 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026 
Standard Chartered Targets Higher Profitability With Major Workforce Cuts 
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks 
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates 
IRVINE, Calif., Sept. 21, 2016 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that the company’s management will be participating in a non-deal roadshow hosted by Mizuho Securities USA Inc. on October 5-6, 2016 in Boston, MA and New York, NY.
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
Investor & Media Inquiries: (949) 679-0410
